HETEROARYLAMIDE ALS INHIBITOREN DER PROTEINAGGREGATION

Patent europeic · EP3348556 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3348556
Numer da la dumonda
EP18156929
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
28-01-2015
Publitgà
18-07-2018
Concedì
29-04-2020
La protecziun finescha il pli tard
27-01-2035
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
C07D 417/14 (2006.01)
A61K 31/4045 (2006.01)
A61P 25/28 (2006.01)
C07D 403/12 (2006.01)
C07D 413/12 (2006.01)
C07D 417/12 (2006.01)
Prioritad
US 201461933246 P 29.01.2014
US 201462078895 P 12.11.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  5. 09-01-2023

    Adressa midada

    Representative
    ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 09.01.2023

  6. 17-07-2020

    Represchentant inscrit

    Representative
    ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich

    Published in Swissreg on 17.07.2020

  7. 29-04-2020

    Concedì

    Published in Swissreg on 29.04.2020

Partidas

Possessur

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Represchentant

Servopatent GmbH

Bühlstrasse 1, 8125 Zollikerberg

Inventur

WRASIDLO, Wolfgang

San Diego, CA 92121, US

STOCKING, Emily M.

San Diego, CA 92121, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.